FDG positron emission tomography/computed tomography  findings for the prediction of early recurrence of hepatocellular carcinoma after surgical resection

Hiraoka,Atsushi; Ochi,Hironori; Hidaka,Satoshi; Uehara,Takahide; Hasebe,Aki; Tanihira,Tetsuya; Miyamoto,Yasunao; Ninomiya,Tomoyuki; Kawasaki,Hideki; Sogabe,Ichiro; Ishimaru,Yoshihiro; Miyagawa,Masao; Furuya,Keizo; Hirooka,Masashi; Abe,Masanori; Hiasa,Yoichi; Matsuura,Bunzo; Onji,Morikazu; Michitaka,Kojiro

doi:10.3892/etm.2010.126

September-October 2010 Volume 1 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September-October 2010 Volume 1 Issue 5

Full Size Image

Article Open Access

FDG positron emission tomography/computed tomography findings for the prediction of early recurrence of hepatocellular carcinoma after surgical resection

Authors:
- Atsushi Hiraoka
- Hironori Ochi
- Satoshi Hidaka
- Takahide Uehara
- Aki Hasebe
- Tetsuya Tanihira
- Yasunao Miyamoto
- Tomoyuki Ninomiya
- Hideki Kawasaki
- Ichiro Sogabe
- Yoshihiro Ishimaru
- Masao Miyagawa
- Keizo Furuya
- Masashi Hirooka
- Masanori Abe
- Yoichi Hiasa
- Bunzo Matsuura
- Morikazu Onji
- Kojiro Michitaka
View Affiliations / Copyright

Affiliations: Gastroenterology Center, Ehime Prefectural Central Hospital, Ehime 790-0024, Japan, Department of Surgery, Ehime Prefectural Central Hospital, Ehime 790-0024, Japan, Department of Radiology, Ehime Prefectural Central Hospital, Ehime 790-0024, Japan, Department of Pathology, Ehime Prefectural Central Hospital, Ehime 790-0024, Japan, Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan
Pages: 829-832
|
Published online on: July 21, 2010

https://doi.org/10.3892/etm.2010.126
Expand metrics +

Abstract

We investigated the predictive value of fluorine-18-fluorodenoxyglucose positron emission tomography/computed tomography for pathological malignant potential and early recurrence of hepatocellular carcinoma (HCC) after resection. From April 2006 to October 2009, 53 patients with naïve HCC were enrolled. Accumulations of 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) standardized uptake value (SUVmax) in both HCC and non-HCC areas of the liver as well as the ratio of SUVmax (R-SUV; HCC/liver) were calculated. The results were evaluated to determine prognostic factors for early recurrence. One patient was graded as tumor node metastasis stage I, 35 as II, 14 as III and 3 as stage IV. Elevated protein induced by vitamin K absence or antagonist II (≥200 mAU/ml) as well as elevated fucosylated α-fetoprotein (≥15%), tumor size (≥5 cm) and high R-SUV (≥1.5) were risk factors for early recurrence in a univariate analysis (P<0.05). In a multivariate analysis, high R-SUV (≥1.5) was the only risk factor (P<0.05). The recurrence-free rate in patients with low R-SUV (<1.5, n=34) was higher than that in those with high R-SUV (≥1.5, n=19) (1- and 2-year rates: 100 and 67%, 67 and 17%; respectively, P<0.01). Patients with Edmondson III showed higher R-SUV values than those with Edmondson I and II (3.0±1.8, 1.4±0.3 and 1.9±0.9, respectively, P<0.01), while those with micro-vascular invasion (vp)(+), micro-intrahepatic metastasis (im)(+) or non-boundary type showed higher R-SUV values than vp(-), im(-) and boundary type (3.6±2.4 vs. 2.0±0.9, 3.5±2.3 vs. 1.9±0.8 and 2.9±1.8 vs. 1.6±0.5, respectively, P<0.01). R-SUV is proposed to be a useful marker for the prediction of early recurrence of HCC after resection.

View Figures

View References

1.	Shiomi S, Nishiguchi S, Ishizu H, et al: Usefulness of positron emission tomography with fluorine-18-fluorodenoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol. 96:1877–1880. 2001. View Article : Google Scholar : PubMed/NCBI
2.	Hatano E, Ikai I, Higashi T, et al: Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose in predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg. 30:1736–1741. 2006. View Article : Google Scholar
3.	Kawamura E, Habu D, Ohfuji S, et al: Clinical role of FDG-PET for HCC: relationship of glucose metabolic indicator to Japan Integrated Staging (JIS) score. Hepatogastroenterology. 55:582–586. 2008.PubMed/NCBI
4.	Arii S, Yamaoka Y, Futagawa S, et al: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 32:1224–1229. 2000. View Article : Google Scholar
5.	Ikai I, Arii S, Kojiro M, et al: Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 101:796–802. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Arii S, Tanaka J, Yamazoe Y, et al: Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer. 69:913–919. 1992. View Article : Google Scholar : PubMed/NCBI
7.	Masuda T, Beppu T, Horino K, et al: Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma. J Surg Oncol. Nov 24–2009.(E-pub ahead of print).
8.	Komura T, Mizukoshi E, Kita Y, et al: Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis. Am J Gastroenterol. 102:1939–1946. 2007. View Article : Google Scholar : PubMed/NCBI
9.	Takuma Y, Nouso K, Makino Y, et al: Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinoma. Liver Int. 27:620–626. 2007. View Article : Google Scholar : PubMed/NCBI
10.	Poon RT, Ng IO, Fan ST, et al: Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol. 19:3037–3044. 2001.PubMed/NCBI
11.	Stroffolini T, Andreone P, Andriulli A, et al: Gross pathologic types of hepatocellular carcinoma in Italy. Oncology. 56:189–192. 1999. View Article : Google Scholar : PubMed/NCBI
12.	Iguchi T, Aishima S, Sanefuji K, et al: Both fibrous capsule formation and extracapsular penetration are powerful predictors of poor survival in human hepatocellular carcinoma: a histological assessment of 365 patients in Japan. Ann Surg Oncol. 16:2539–2546. 2009. View Article : Google Scholar
13.	Edmondson HA and Steiner PE: Primary carcinoma of the liver. A study of 100 cases among 48900 necrosis necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
14.	Trojan J, Schroeder O, Raedle J, et al: Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol. 94:3314–3319. 1999. View Article : Google Scholar : PubMed/NCBI
15.	Yoon KT, Kim JK, Kim DY, et al: Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology. 72:104–110. 2007. View Article : Google Scholar
16.	Sugiyama M, Sakahara H, Torizuka T, et al: 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol. 39:961–968. 2004. View Article : Google Scholar : PubMed/NCBI
17.	Lee JW, Paeng JC, Kang KW, et al: Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med. 50:682–687. 2009. View Article : Google Scholar : PubMed/NCBI
18.	Komberg A, Freesmeyer M, Barthel E, et al: 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant. 9:592–600. 2009. View Article : Google Scholar : PubMed/NCBI
19.	Sumie S, Kuromatsu R, Okuda K, et al: Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 15:1375–1382. 2008. View Article : Google Scholar : PubMed/NCBI